Kaposi Sarcoma-associated Herpesvirus: Mechanisms of oncogenesis

Current Opinion in Virology

Volumn 14, Issue , 2015, Pages 116-128

  Schulz, Thomas F ^a,b   Cesarman, Ethel ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Centre of Infection Research   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN; RNA; VIRUS PROTEIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MULTICENTRIC CASTLEMAN DISEASE; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; HOST PATHOGEN INTERACTION; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

CARCINOGENESIS; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOMA, PRIMARY EFFUSION; SARCOMA, KAPOSI;

EID: 84942883242     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.08.016     Document Type: Review

References (199)

1. Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, and P.S. Moore Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
2. G. Cathomas, C.E. McGandy, L.M. Terracciano, P.H. Itin, G. De Rosa, and F. Gudat Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma J Clin Pathol 49 1996 631 633
3. D. Whitby, M.R. Howard, M. Tenant-Flowers, N.S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F.E. Suggett, D.M. Aldam, A.S. Denton, and et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma Lancet 346 1995 799 802
4. T.R. O'Brien, D. Kedes, D. Ganem, D.R. Macrae, P.S. Rosenberg, J. Molden, and J.J. Goedert Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma J Infect Dis 180 1999 1010 1017
5. E. Cesarman, Y. Chang, P.S. Moore, J.W. Said, and D.M. Knowles Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas N Engl J Med 332 1995 1186 1191
6. J. Soulier, L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, M.F. d'Agay, J.P. Clauvel, M. Raphael, L. Degos, and et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease Blood 86 1995 1276 1280
7. Biological agents Volume 100 B. A review of human carcinogens IARC Monogr Eval Carcinog Risks Hum 100 2012 1 441
8. A.E. Grulich, M.T. van Leeuwen, M.O. Falster, and C.M. Vajdic Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 2007 59 67
9. M. Dedicoat, and R. Newton Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma Br J Cancer 88 2003 1 3
10. D. Whitby, V.A. Marshall, R.K. Bagni, W.J. Miley, T.G. McCloud, R. Hines-Boykin, J.J. Goedert, B.A. Conde, K. Nagashima, J. Mikovits, and et al. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions Int J Cancer 120 2007 321 328
11. J.G. Judde, V. Lacoste, J. Briere, E. Kassa-Kelembho, E. Clyti, P. Couppie, C. Buchrieser, M. Tulliez, J. Morvan, and A. Gessain Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases J Natl Cancer Inst 92 2000 729 736
12. E. Delabesse, E. Oksenhendler, C. Lebbe, O. Verola, B. Varet, and A.G. Turhan Molecular analysis of clonality in Kaposi's sarcoma J Clin Pathol 50 1997 664 668
13. P.S. Gill, Y.C. Tsai, A.P. Rao, C.H. Spruck 3rd, T. Zheng, W.A. Harrington Jr., T. Cheung, B. Nathwani, and P.A. Jones Evidence for multiclonality in multicentric Kaposi's sarcoma Proc Natl Acad Sci U S A 95 1998 8257 8261
14. T. Jones, F. Ye, R. Bedolla, Y. Huang, J. Meng, L. Qian, H. Pan, F. Zhou, R. Moody, B. Wagner, and et al. Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV J Clin Invest 122 2012 1076 1081
15. A.D. Mutlu, L.E. Cavallin, L. Vincent, C. Chiozzini, P. Eroles, E.M. Duran, Z. Asgari, A.T. Hooper, K.M. La Perle, C. Hilsher, and et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma Cancer Cell 11 2007 245 258
16. F.Q. An, H.M. Folarin, N. Compitello, J. Roth, S.L. Gerson, K.R. McCrae, F.D. Fakhari, D.P. Dittmer, and R. Renne Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo J Virol 80 2006 4833 4846
17. F. Scinicariello, M.J. Dolan, I. Nedelcu, S.K. Tyring, and J.K. Hilliard Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma Virology 203 1994 153 157
18. J.J. Li, Y.Q. Huang, C.J. Cockerell, W.G. Zhang, A. Nicolaides, and A.E. Friedman-Kien Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma Am J Dermatopathol 19 1997 373 378
19. A. Nicolaides, Y.Q. Huang, J.J. Li, W.G. Zhang, and A.E. Friedman-Kien Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma Anticancer Res 14 1994 921 926
20. O. Flore, S. Rafii, S. Ely, J.J. O'Leary, E.M. Hyjek, and E. Cesarman Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus Nature 394 1998 588 592
21. L. Wang, and B. Damania Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells Cancer Res 68 2008 4640 4648
22. E.E. Kaaya, C. Parravicini, B. Sundelin, E. Mgaya, J. Kitinya, L. Lema, J. Luande, and P. Biberfeld Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma Eur J Cancer 28A 1992 1890 1894
23. E. Hodak, I. Hammel, M. Feinmesser, A. Zelinger, L. Maron, J. Sulkes, and M. David Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma Am J Dermatopathol 21 1999 138 145
24. S. Montaner, A. Sodhi, A. Molinolo, T.H. Bugge, E.T. Sawai, Y. He, Y. Li, P.E. Ray, and J.S. Gutkind Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes Cancer Cell 3 2003 23 36
25. C.C. Tomlinson, and B. Damania The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway J Virol 78 2004 1918 1927
26. A. Sodhi, R. Chaisuparat, J. Hu, A.K. Ramsdell, B.D. Manning, E.A. Sausville, E.T. Sawai, A. Molinolo, J.S. Gutkind, and S. Montaner The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor Cancer Cell 10 2006 133 143
27. V.A. Morris, A.S. Punjabi, and M. Lagunoff Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells J Virol 82 2008 8771 8779
28. H.H. Chang, and D. Ganem A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity Cell Host Microbe 13 2013 429 440
29. G. Stallone, A. Schena, B. Infante, S. Di Paolo, A. Loverre, G. Maggio, E. Ranieri, L. Gesualdo, F.P. Schena, and G. Grandaliano Sirolimus for Kaposi's sarcoma in renal-transplant recipients N Engl J Med 352 2005 1317 1323
30. P.M. Ojala, and T.F. Schulz Manipulation of endothelial cells by KSHV: Implications for angiogenesis and aberrant vascular differentiation Semin Cancer Biol 2014
31. F. Cheng, P. Pekkonen, S. Laurinavicius, N. Sugiyama, S. Henderson, T. Gunther, V. Rantanen, E. Kaivanto, M. Aavikko, G. Sarek, and et al. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition Cell Host Microbe 10 2011 577 590
32. H.W. Wang, M.W. Trotter, D. Lagos, D. Bourboulia, S. Henderson, T. Makinen, S. Elliman, A.M. Flanagan, K. Alitalo, and C. Boshoff Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma Nat Genet 36 2004 687 693
33. Y.K. Hong, K. Foreman, J.W. Shin, S. Hirakawa, C.L. Curry, D.R. Sage, T. Libermann, B.J. Dezube, J.D. Fingeroth, and M. Detmar Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus Nat Genet 36 2004 683 685
34. C. Grossmann, S. Podgrabinska, M. Skobe, and D. Ganem Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype J Virol 80 2006 7179 7185
35. K.R. Alkharsah, V.V. Singh, R. Bosco, S. Santag, A. Grundhoff, A. Konrad, M. Sturzl, D. Wirth, O. Dittrich-Breiholz, M. Kracht, and et al. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells J Virol 85 2011 10375 10388
36. G. Ballon, G. Akar, and E. Cesarman Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo PLoS Pathog 11 2015 e1004581
37. L.W. Qian, J. Xie, F. Ye, and S.J. Gao Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases J Virol 81 2007 7001 7010
38. K. Bala, R. Bosco, S. Gramolelli, D.A. Haas, S. Kati, M. Pietrek, A. Havemeier, Y. Yakushko, V.V. Singh, O. Dittrich-Breiholz, and et al. Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression PLoS Pathog 8 2012 e1002927
39. D.A. Haas, K. Bala, G. Busche, M. Weidner-Glunde, S. Santag, S. Kati, S. Gramolelli, M. Damas, O. Dittrich-Breiholz, M. Kracht, and et al. The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells PLoS Pathog 9 2013 e1003737
40. S. Gramolelli, M. Weidner-Glunde, B. Abere, A. Viejo-Borbolla, K. Bala, J. Ruckert, E. Kremmer, and T.F. Schulz Inhibiting the recruitment of PLCgamma1 to Kaposi's Sarcoma herpesvirus K15 protein reduces the invasiveness and angiogenesis of infected endothelial cells PLoS Pathog 11 2015 e1005105
41. M. He, W. Zhang, T. Bakken, M. Schutten, Z. Toth, J.U. Jung, P. Gill, M. Cannon, and S.J. Gao Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2 Cancer Res 72 2012 3582 3592
42. Z. Qin, L. Dai, M.G. Slomiany, B.P. Toole, and C. Parsons Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus Cancer Res 70 2012 3884 3889
43. R. Masood, E. Cesarman, D.L. Smith, P.S. Gill, and O. Flore Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor Am J Pathol 160 2002 23 29
44. X. Wang, Z. He, T. Xia, X. Li, D. Liang, X. Lin, H. Wen, and K. Lan Latency-associated nuclear antigen of kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1 Cancer Res 74 2014 2026 2037
45. A.V. Moses, M.A. Jarvis, C. Raggo, Y.C. Bell, R. Ruhl, B.G. Luukkonen, D.J. Griffith, C.L. Wait, B.J. Druker, M.C. Heinrich, and et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells J Virol 76 2002 8383 8399
46. H.B. Koon, G.J. Bubley, L. Pantanowitz, D. Masiello, B. Smith, K. Crosby, J. Proper, W. Weeden, T.E. Miller, P. Chatis, and et al. Imatinib-induced regression of AIDS-related Kaposi's sarcoma J Clin Oncol 23 2005 982 989
47. H.B. Koon, S.E. Krown, J.Y. Lee, K. Honda, S. Rapisuwon, Z. Wang, D. Aboulafia, E.G. Reid, M.A. Rudek, B.J. Dezube, and et al. Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042 J Clin Oncol 32 2014 402 408
48. G. Weiss, A. Shemer, and H. Trau The Koebner phenomenon: review of the literature J Eur Acad Dermatol Venereol 16 2002 241 248
49. P. Monini, S. Colombini, M. Sturzl, D. Goletti, A. Cafaro, C. Sgadari, S. Butto, M. Franco, P. Leone, S. Fais, and et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma Blood 93 1999 4044 4058
50. M.C. Sirianni, L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, and et al. gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages Blood 91 1998 968 976
51. S.Z. Salahuddin, S. Nakamura, P. Biberfeld, M.H. Kaplan, P.D. Markham, L. Larsson, and R.C. Gallo Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro Science 242 1988 430 433
52. W. Grayson, and L. Pantanowitz Histological variants of cutaneous Kaposi sarcoma Diagn Pathol 3 2008 31
53. C. Parravicini, B. Chandran, M. Corbellino, E. Berti, M. Paulli, P.S. Moore, and Y. Chang Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease Am J Pathol 156 2000 743 749
54. H. Katano, Y. Sato, T. Kurata, S. Mori, and T. Sata Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease Virology 269 2000 335 344
55. N. Sharma-Walia, A.G. Paul, V. Bottero, S. Sadagopan, M.V. Veettil, N. Kerur, and B. Chandran Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion PLoS Pathog 6 2010 e1000777
56. L. Rainbow, G.M. Platt, G.R. Simpson, R. Sarid, S.J. Gao, H. Stoiber, C.S. Herrington, and P.S. Moore Schulz TF: The 222- to 234-kDa latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen J Virol 71 1997 5915 5921
57. N. Dupin, C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. van Marck, D. Salmon, I. Gorin, J.P. Escande, and et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma Proc Natl Acad Sci U S A 96 1999 4546 4551
58. M. Sturzl, C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Esser, N.H. Brockmeyer, M. Ekman, and et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma Int J Cancer 72 1997 68 71
59. M.A. Davis, M.A. Sturzl, C. Blasig, A. Schreier, H.G. Guo, M. Reitz, S.R. Opalenik, and P.J. Browning Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells J Natl Cancer Inst 89 1997 1868 1874
60. M.C. Hosseinipour, K.M. Sweet, J. Xiong, D. Namarika, A. Mwafongo, M. Nyirenda, L. Chiwoko, D. Kamwendo, I. Hoffman, J. Lee, and et al. Viral profiling identifies multiple subtypes of Kaposi's sarcoma MBio 5 2014 e01633 e01634
61. A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T.F. Schulz HIV-associated lymphomas and gamma-herpesviruses Blood 113 2009 1213 1224
62. G. Gaidano, D. Capello, A.M. Cilia, A. Gloghini, T. Perin, S. Quattrone, A. Migliazza, F. Lo Coco, G. Saglio, V. Ascoli, and et al. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis Genes Chromosom Cancer 24 1999 16 23
63. A. Matolcsy, R.G. Nador, E. Cesarman, and D.M. Knowles Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation Am J Pathol 153 1998 1609 1614
64. R.G. Jenner, K. Maillard, N. Cattini, R.A. Weiss, C. Boshoff, R. Wooster, and P. Kellam Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile Proc Natl Acad Sci U S A 100 2003 10399 10404
65. I. Guasparri, S.A. Keller, and E. Cesarman KSHV vFLIP is essential for the survival of infected lymphoma cells J Exp Med 199 2004 993 1003
66. A. Godfrey, J. Anderson, A. Papanastasiou, Y. Takeuchi, and C. Boshoff Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA Blood 105 2005 2510 2518
67. S.A. Keller, E.J. Schattner, and E. Cesarman Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood 96 2000 2537 2542
68. J. An, Y. Sun, R. Sun, and M.B. Rettig Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways Oncogene 22 2003 3371 3385
69. G. Sarek, S. Kurki, J. Enback, G. Iotzova, J. Haas, P. Laakkonen, M. Laiho, and P.M. Ojala Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas J Clin Invest 117 2007 1019 1028
70. S. Santag, W. Jager, C.B. Karsten, S. Kati, M. Pietrek, D. Steinemann, G. Sarek, P.M. Ojala, and T.F. Schulz Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells Oncogene 32 2013 3676 3685
71. C. Rivas, A.E. Thlick, C. Parravicini, P.S. Moore, and Y. Chang Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 J Virol 75 2001 429 438
72. E. Wies, Y. Mori, A. Hahn, E. Kremmer, M. Sturzl, B. Fleckenstein, and F. Neipel The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells Blood 111 2008 320 327
73. Y. Aoki, E.S. Jaffe, Y. Chang, K. Jones, J. Teruya-Feldstein, P.S. Moore, and G. Tosato Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 Blood 93 1999 4034 4043
74. S. Lumley, S. Madge, D. Nugent, J. Ainsworth, S. Dervisevic, C. Schmitt, T.F. Schulz, M.A. Johnson, K. Cwynarski, and D.P. Webster High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy AIDS 28 2014 1698 1700
75. E. Oksenhendler, G. Carcelain, Y. Aoki, E. Boulanger, A. Maillard, J.P. Clauvel, and F. Agbalika High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients Blood 96 2000 2069 2073
76. 18F-fluorodeoxyglucose positron emission tomography in Kaposi Sarcoma herpesvirus-associated multicentric castleman disease: correlation with activity, severity, inflammatory and virologic parameters J Infect Dis 2015
77. M.N. Polizzotto, T.S. Uldrick, D. Hu, and R. Yarchoan Clinical manifestations of Kaposi Sarcoma herpesvirus lytic activation: multicentric castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome Front Microbiol 3 2012 73
78. T.S. Uldrick, V. Wang, D. O'Mahony, K. Aleman, K.M. Wyvill, V. Marshall, S.M. Steinberg, S. Pittaluga, I. Maric, D. Whitby, and et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease Clin Infect Dis 51 2010 350 358
79. D.H. Kedes, M. Lagunoff, R. Renne, and D. Ganem Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus J Clin Invest 100 1997 2606 2610
80. J. Friborg Jr., W. Kong, and M.O. Hottiger Nabel GJ: p53 inhibition by the LANA protein of KSHV protects against cell death Nature 402 1999 889 894
81. S.A. Radkov, P. Kellam, and C. Boshoff The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells Nat Med 6 2000 1121 1127
82. T. Watanabe, M. Sugaya, A.M. Atkins, E.A. Aquilino, A. Yang, D.L. Borris, J. Brady, and A. Blauvelt Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells J Virol 77 2003 6188 6196
83. F.C. Ye, F.C. Zhou, S.M. Yoo, J.P. Xie, P.J. Browning, and S.J. Gao Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence J Virol 78 2004 11121 11129
84. J. Liu, H.J. Martin, G. Liao, and S.D. Hayward The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc J Virol 81 2007 10451 10459
85. D. Bubman, I. Guasparri, and E. Cesarman Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen Oncogene 26 2007 4979 4986
86. M. Fujimuro, F.Y. Wu, C. ApRhys, H. Kajumbula, D.B. Young, G.S. Hayward, and S.D. Hayward A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency Nat Med 9 2003 300 306
87. K.R. Alkharsah, and T.F. Schulz A role for the internal repeat of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen in the persistence of an episomal viral genome J Virol 86 2012 1883 1887
88. Y. Chang, P.S. Moore, S.J. Talbot, C.H. Boshoff, T. Zarkowska, K. Godden, H. Paterson, R.A. Weiss, and S. Mittnacht Cyclin encoded by KS herpesvirus Nature 382 1996 410
89. D. Godden-Kent, S.J. Talbot, C. Boshoff, Y. Chang, P. Moore, R.A. Weiss, and S. Mittnacht The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 J Virol 71 1997 4193 4198
90. C. Swanton, D.J. Mann, B. Fleckenstein, F. Neipel, G. Peters, and N. Jones Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins Nature 390 1997 184 187
91. E.W. Verschuren, J.G. Hodgson, J.W. Gray, S. Kogan, N. Jones, and G.I. Evan The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis Cancer Res 64 2004 581 589
92. S. Koopal, J.H. Furuhjelm, A. Jarviluoma, S. Jaamaa, P. Pyakurel, C. Pussinen, M. Wirzenius, P. Biberfeld, K. Alitalo, M. Laiho, and et al. Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis PLoS Pathog 3 2007 1348 1360
93. G. Sarek, A. Jarviluoma, H.M. Moore, S. Tojkander, S. Vartia, P. Biberfeld, M. Laiho, and P.M. Ojala Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency PLoS Pathog 6 2010 e1000818
94. T. Jones, S. Ramos da Silva, R. Bedolla, F. Ye, F. Zhou, and S.J. Gao Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition Cell Cycle 13 2014 845 858
95. L. Liu, M.T. Eby, N. Rathore, S.K. Sinha, A. Kumar, and P.M. Chaudhary The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex J Biol Chem 277 2002 13745 13751
96. N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins KSHV vFLIP binds to IKK-gamma to activate IKK J Cell Sci 116 2003 3721 3728
97. F.C. Ye, F.C. Zhou, J.P. Xie, T. Kang, W. Greene, K. Kuhne, X.F. Lei, Q.H. Li, and S.J. Gao Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency J Virol 82 2008 4235 4249
98. P. Chugh, H. Matta, S. Schamus, S. Zachariah, A. Kumar, J.A. Richardson, A.L. Smith, and P.M. Chaudhary Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice Proc Natl Acad Sci U S A 102 2005 12885 12890
99. C. Bagneris, A.V. Ageichik, N. Cronin, B. Wallace, M. Collins, C. Boshoff, G. Waksman, and T. Barrett Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome Mol Cell 30 2008 620 631
100. J.S. Lee, Q. Li, J.Y. Lee, S.H. Lee, J.H. Jeong, H.R. Lee, H. Chang, F.C. Zhou, S.J. Gao, C. Liang, and et al. FLIP-mediated autophagy regulation in cell death control Nat Cell Biol 11 2009 1355 1362
101. V. Emuss, D. Lagos, A. Pizzey, F. Gratrix, S.R. Henderson, and C. Boshoff KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia PLoS Pathog 5 2009 e1000616
102. G. Ballon, K. Chen, R. Perez, W. Tam, and E. Cesarman Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice J Clin Invest 121 2011 1141 1153
103. A.M. Leidal, D.P. Cyr, R.J. Hill, P.W. Lee, and C. McCormick Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence Cell Host Microbe 11 2012 167 180
104. V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, N. Paudel, L. Chikoti, and B. Chandran Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes J Virol 87 2013 4417 4431
105. T.Y. Yang, S.C. Chen, M.W. Leach, D. Manfra, B. Homey, M. Wiekowski, L. Sullivan, C.H. Jenh, S.K. Narula, S.W. Chensue, and et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma J Exp Med 191 2000 445 454
106. S. Montaner, A. Sodhi, S. Pece, E.A. Mesri, and J.S. Gutkind The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B Cancer Res 61 2001 2641 2648
107. C. Bais, A. Van Geelen, P. Eroles, A. Mutlu, C. Chiozzini, S. Dias, R.L. Silverstein, S. Rafii, and E.A. Mesri Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR Cancer Cell 3 2003 131 143
108. A. Sodhi, S. Montaner, V. Patel, J.J. Gomez-Roman, Y. Li, E.A. Sausville, E.T. Sawai, and J.S. Gutkind Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor Proc Natl Acad Sci U S A 101 2004 4821 4826
109. R.J. Vart, L.L. Nikitenko, D. Lagos, M.W. Trotter, M. Cannon, D. Bourboulia, F. Gratrix, Y. Takeuchi, and C. Boshoff Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells Cancer Res 67 2007 4042 4051
110. D. Lagos, R.J. Vart, F. Gratrix, S.J. Westrop, V. Emuss, P.P. Wong, R. Robey, N. Imami, M. Bower, F. Gotch, and et al. Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus Cell Host Microbe 4 2008 470 483
111. G. Sandford, Y.B. Choi, and J. Nicholas Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication J Virol 83 2009 13009 13014
112. T. Ma, B.C. Jham, J. Hu, E.R. Friedman, J.R. Basile, A. Molinolo, A. Sodhi, and S. Montaner Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma Proc Natl Acad Sci U S A 107 2010 14363 14368
113. D. Martin, R. Galisteo, A.A. Molinolo, R. Wetzker, E. Hirsch, and J.S. Gutkind PI3Kgamma mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis Cancer Cell 19 2011 805 813
114. H. Lee, R. Veazey, K. Williams, M. Li, J. Guo, F. Neipel, B. Fleckenstein, A. Lackner, R.C. Desrosiers, and J.U. Jung Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus Nat Med 4 1998 435 440
115. M. Lagunoff, R. Majeti, A. Weiss, and D. Ganem Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus Proc Natl Acad Sci U S A 96 1999 5704 5709
116. B.S. Lee, X. Alvarez, S. Ishido, A.A. Lackner, and J.U. Jung Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1 J Exp Med 192 2000 11 21
117. M. Lagunoff, D.M. Lukac, and D. Ganem Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication J Virol 75 2001 5891 5898
118. O. Prakash, Z.Y. Tang, X. Peng, R. Coleman, J. Gill, G. Farr, and F. Samaniego Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene J Natl Cancer Inst 94 2002 926 935
119. B.S. Lee, M. Paulose-Murphy, Y.H. Chung, M. Connlole, S. Zeichner, and J.U. Jung Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction J Virol 76 2002 12185 12199
120. L. Wang, N. Wakisaka, C.C. Tomlinson, S.M. DeWire, S. Krall, J.S. Pagano, and B. Damania The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors Cancer Res 64 2004 2774 2781
121. J. Douglas, B. Dutia, S. Rhind, J.P. Stewart, and S.J. Talbot Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus J Virol 78 2004 8878 8884
122. L. Wang, D.P. Dittmer, C.C. Tomlinson, F.D. Fakhari, and B. Damania Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus Cancer Res 66 2006 3658 3666
123. C. Guilluy, Z. Zhang, P.M. Bhende, L. Sharek, L. Wang, K. Burridge, and B. Damania Latent KSHV infection increases the vascular permeability of human endothelial cells Blood 118 2011 5344 5354
124. L. Steinbruck, M. Gustems, S. Medele, T.F. Schulz, D. Lutter, and W. Hammerschmidt K1 and K15 of Kaposi's Sarcoma-associated herpesvirus are partial functional homologues of latent membrane protein 2A of Epstein-Barr virus J Virol 89 2015 7248 7261
125. M. Glenn, L. Rainbow, F. Aurade, A. Davison, and T.F. Schulz Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus J Virol 73 1999 6953 6963
126. L.J. Poole, J.C. Zong, D.M. Ciufo, D.J. Alcendor, J.S. Cannon, R. Ambinder, J.M. Orenstein, M.S. Reitz, and G.S. Hayward Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end J Virol 73 1999 6646 6660
127. M.M. Brinkmann, M. Glenn, L. Rainbow, A. Kieser, C. Henke-Gendo, and T.F. Schulz Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein J Virol 77 2003 9346 9358
128. M.M. Brinkmann, M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T.F. Schulz Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus J Virol 81 2007 42 58
129. M. Pietrek, M.M. Brinkmann, I. Glowacka, A. Enlund, A. Havemeier, O. Dittrich-Breiholz, M. Kracht, M. Lewitzky, K. Saksela, S.M. Feller, and et al. Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation J Virol 84 2010 8231 8240
130. A. Havemeier, S. Gramolelli, M. Pietrek, R. Jochmann, M. Sturzl, and T.F. Schulz Activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-kappaB-inducing kinase, IkappaB kinases, and phosphorylation of p65 J Virol 88 2014 13161 13172
131. P.S. Moore, C. Boshoff, R.A. Weiss, and Y. Chang Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV Science 274 1996 1739 1744
132. F. Neipel, J.C. Albrecht, A. Ensser, Y.Q. Huang, J.J. Li, A.E. Friedman-Kien, and B. Fleckenstein Human herpesvirus 8 encodes a homolog of interleukin-6 J Virol 71 1997 839 842
133. J. Nicholas, V. Ruvolo, J. Zong, D. Ciufo, H.G. Guo, M.S. Reitz, and G.S. Hayward A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins J Virol 71 1997 1963 1974
134. J. Molden, Y. Chang, Y. You, P.S. Moore, and M.A. Goldsmith A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit J Biol Chem 272 1997 19625 19631
135. C. Parravicini, M. Corbellino, M. Paulli, U. Magrini, M. Lazzarino, P.S. Moore, and Y. Chang Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease Am J Pathol 151 1997 1517 1522
136. R. Burger, F. Neipel, B. Fleckenstein, R. Savino, G. Ciliberto, J.R. Kalden, and M. Gramatzki Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells Blood 91 1998 1858 1863
137. E. Cousins, Y. Gao, G. Sandford, and J. Nicholas Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells J Virol 88 2014 12167 12172
138. K.D. Jones, Y. Aoki, Y. Chang, P.S. Moore, R. Yarchoan, and G. Tosato Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells Blood 94 1999 2871 2879
139. Y. Mori, N. Nishimoto, M. Ohno, R. Inagi, P. Dhepakson, K. Amou, K. Yoshizaki, and K. Yamanishi Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion J Med Virol 61 2000 332 335
140. V.A. Morris, A.S. Punjabi, R.C. Wells, C.J. Wittkopp, R. Vart, and M. Lagunoff The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation Virology 428 2012 112 120
141. M.N. Polizzotto, T.S. Uldrick, V. Wang, K. Aleman, K.M. Wyvill, V. Marshall, S. Pittaluga, D. O'Mahony, D. Whitby, G. Tosato, and et al. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease Blood 122 2013 4189 4198
142. J. Suthaus, C. Stuhlmann-Laeisz, V.S. Tompkins, T.R. Rosean, W. Klapper, G. Tosato, S. Janz, J. Scheller, and S. Rose-John HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice Blood 119 2012 5173 5181
143. X. Wan, H. Wang, and J. Nicholas Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6 J Virol 73 1999 8268 8278
144. X. Zhu, Y. Guo, S. Yao, Q. Yan, M. Xue, T. Hao, F. Zhou, J. Zhu, D. Qin, and C. Lu Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway Oncogene 33 2013 1986 1996
145. C. Boshoff, Y. Endo, P.D. Collins, Y. Takeuchi, J.D. Reeves, V.L. Schweickart, M.A. Siani, T. Sasaki, T.J. Williams, P.W. Gray, and et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines Science 278 1997 290 294
146. Y.B. Choi, and J. Nicholas Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines J Virol 82 2008 6501 6513
147. M.J. Endres, C.G. Garlisi, H. Xiao, L. Shan, and J.A. Hedrick The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8 J Exp Med 189 1999 1993 1998
148. T.N. Kledal, M.M. Rosenkilde, F. Coulin, G. Simmons, A.H. Johnsen, S. Alouani, C.A. Power, H.R. Luttichau, J. Gerstoft, P.R. Clapham, and et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus Science 277 1997 1656 1659
149. J.T. Stine, C. Wood, M. Hill, A. Epp, C.J. Raport, V.L. Schweickart, Y. Endo, T. Sasaki, G. Simmons, C. Boshoff, and et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells Blood 95 2000 1151 1157
150. K.S. Weber, H.J. Grone, M. Rocken, C. Klier, S. Gu, R. Wank, A.E. Proudfoot, P.J. Nelson, and C. Weber Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II Eur J Immunol 31 2001 2458 2466
151. Y.B. Choi, and J. Nicholas Bim nuclear translocation and inactivation by viral interferon regulatory factor PLoS Pathog 6 2010 e1001031
152. Y.B. Choi, G. Sandford, and J. Nicholas Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry PLoS Pathog 8 2012 e1002748
153. S.J. Gao, C. Boshoff, S. Jayachandra, R.A. Weiss, Y. Chang, and P.S. Moore KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway Oncogene 15 1997 1979 1985
154. S. Kirchhoff, T. Sebens, S. Baumann, A. Krueger, R. Zawatzky, M. Li-Weber, E. Meinl, F. Neipel, B. Fleckenstein, and P.H. Krammer Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter J Immunol 168 2002 1226 1234
155. R. Lin, P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, W.J. Harrington Jr., G.N. Barber, and J. Hiscott HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators Oncogene 20 2001 800 811
156. Z. Ma, S.R. Jacobs, J.A. West, C. Stopford, Z. Zhang, Z. Davis, G.N. Barber, B.A. Glaunsinger, D.P. Dittmer, and B. Damania Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses Proc Natl Acad Sci U S A 112 2015 E4306 E4315
157. T. Seo, D. Lee, Y.S. Shim, J.E. Angell, N.V. Chidambaram, D.V. Kalvakolanu, and J. Choe Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death J Virol 76 2002 8797 8807
158. T. Seo, J. Park, and J. Choe Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling Cancer Res 65 2005 1738 1747
159. Y.C. Shin, H. Nakamura, X. Liang, P. Feng, H. Chang, T.F. Kowalik, and J.U. Jung Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1 J Virol 80 2006 2257 2266
160. L. Burysek, and P.M. Pitha Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase J Virol 75 2001 2345 2352
161. S. Fuld, C. Cunningham, K. Klucher, A.J. Davison, and D.J. Blackbourn Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein J Virol 80 2006 3092 3097
162. M. Mutocheluh, L. Hindle, C. Areste, S.A. Chanas, L.M. Butler, K. Lowry, K. Shah, D.J. Evans, and D.J. Blackbourn Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3 J Gen Virol 92 2011 2394 2398
163. M. Esteban, M.A. Garcia, E. Domingo-Gil, J. Arroyo, C. Nombela, and C. Rivas The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation J Gen Virol 84 2003 1463 1470
164. C.H. Joo, Y.C. Shin, M. Gack, L. Wu, D. Levy, and J.U. Jung Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3 J Virol 81 2007 8282 8292
165. B. Lubyova, M.J. Kellum, J.A. Frisancho, and P.M. Pitha Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus J Biol Chem 282 2007 31944 31953
166. L. Marcos-Villar, F. Lopitz-Otsoa, P. Gallego, C. Munoz-Fontela, J. Gonzalez-Santamaria, M. Campagna, G. Shou-Jiang, M.S. Rodriguez, and C. Rivas Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene J Virol 83 2009 8849 8858
167. K. Schmidt, E. Wies, and F. Neipel Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression J Virol 85 2011 4530 4537
168. T. Seo, J. Park, C. Lim, and J. Choe Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus Oncogene 23 2004 6146 6155
169. Y.C. Shin, C.H. Joo, M.U. Gack, H.R. Lee, and J.U. Jung Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression Cancer Res 68 2008 1751 1759
170. E. Wies, A.S. Hahn, K. Schmidt, C. Viebahn, N. Rohland, A. Lux, T. Schellhorn, A. Holzer, J.U. Jung, and F. Neipel The Kaposi's Sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5 J Biol Chem 284 2009 8525 8538
171. K. Heinzelmann, B.A. Scholz, A. Nowak, E. Fossum, E. Kremmer, J. Haas, R. Frank, and B. Kempkes Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling J Virol 84 2010 12255 12264
172. H.R. Lee, W.C. Choi, S. Lee, J. Hwang, E. Hwang, K. Guchhait, J. Haas, Z. Toth, Y.H. Jeon, T.K. Oh, and et al. Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein Nat Struct Mol Biol 18 2011 1336 1344
173. H.R. Lee, Z. Toth, Y.C. Shin, J.S. Lee, H. Chang, W. Gu, T.K. Oh, M.H. Kim, and J.U. Jung Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway J Virol 83 2009 6739 6747
174. B.A. Scholz, M.L. Harth-Hertle, G. Malterer, J. Haas, J. Ellwart, T.F. Schulz, and B. Kempkes Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines PLoS Pathog 9 2013 e1003336
175. X. Xi, L.M. Persson, M.W. O'Brien, I. Mohr, and A.C. Wilson Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters J Virol 86 2012 1021 1033
176. S. Kliche, W. Nagel, E. Kremmer, C. Atzler, A. Ege, T. Knorr, U. Koszinowski, W. Kolanus, and J. Haas Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1 Mol Cell 7 2001 833 843
177. S. Muralidhar, A.M. Pumfery, M. Hassani, M.R. Sadaie, M. Kishishita, J.N. Brady, J. Doniger, P. Medveczky, and L.J. Rosenthal Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene J Virol 72 1998 4980 4988
178. J.A. Corcoran, B.P. Johnston, and C. McCormick Viral activation of MK2-hsp27-p115RhoGEF-RhoA signaling axis causes cytoskeletal rearrangements, p-body disruption and ARE-mRNA stabilization PLoS Pathog 11 2015 e1004597
179. C.A. King Kaposi's sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28 J Virol 87 2013 8779 8791
180. C. McCormick, and D. Ganem The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs Science 307 2005 739 741
181. J. Yoo, J. Kang, H.N. Lee, B. Aguilar, D. Kafka, S. Lee, I. Choi, J. Lee, S. Ramu, J. Haas, and et al. Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus PLoS Pathog 6 2010 e1001046
182. L. Coscoy, and D. Ganem Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis Proc Natl Acad Sci U S A 97 2000 8051 8056
183. S. Ishido, C. Wang, B.S. Lee, G.B. Cohen, and J.U. Jung Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins J Virol 74 2000 5300 5309
184. L. Coscoy, and D. Ganem A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation J Clin Invest 107 2001 1599 1606
185. S. Ishido, J.K. Choi, B.S. Lee, C. Wang, M. DeMaria, R.P. Johnson, G.B. Cohen, and J.U. Jung Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein Immunity 13 2000 365 374
186. M. Mansouri, K. Viswanathan, J.L. Douglas, J. Hines, J. Gustin, A.V. Moses, and K. Fruh Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus J Virol 83 2009 9672 9681
187. P. Bellare, and D. Ganem Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation Cell Host Microbe 6 2009 570 575
188. I.W. Boss, P.E. Nadeau, J.R. Abbott, Y. Yang, A. Mergia, and R. Renne A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rgammanull mice J Virol 85 2011 9877 9886
189. C. Dahlke, K. Maul, T. Christalla, N. Walz, P. Schult, C. Stocking, and A. Grundhoff A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo PLoS ONE 7 2012 e49435
190. E. Gottwein, and B.R. Cullen A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest J Virol 84 2010 5229 5237
191. E. Gottwein, N. Mukherjee, C. Sachse, C. Frenzel, W.H. Majoros, J.T. Chi, R. Braich, M. Manoharan, J. Soutschek, U. Ohler, and et al. A viral microRNA functions as an orthologue of cellular miR-155 Nature 450 2007 1096 1099
192. A. Hansen, S. Henderson, D. Lagos, L. Nikitenko, E. Coulter, S. Roberts, F. Gratrix, K. Plaisance, R. Renne, M. Bower, and et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming Genes Dev 24 2010 195 205
193. X. Lei, Z. Bai, F. Ye, J. Xie, C.G. Kim, Y. Huang, and S.J. Gao Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA Nat Cell Biol 12 2010 193 199
194. Y. Liu, R. Sun, X. Lin, D. Liang, Q. Deng, and K. Lan Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5 J Virol 86 2012 1372 1381
195. C.C. Lu, Z. Li, C.Y. Chu, J. Feng, J. Feng, R. Sun, and T.M. Rana MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle EMBO Rep 11 2010 784 790
196. F. Lu, W. Stedman, M. Yousef, R. Renne, and P.M. Lieberman Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway J Virol 84 2010 2697 2706
197. R. Moody, Y. Zhu, Y. Huang, X. Cui, T. Jones, R. Bedolla, X. Lei, Z. Bai, and S.J. Gao KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways PLoS Pathog 9 2013 e1003857
198. D. Nachmani, N. Stern-Ginossar, R. Sarid, and O. Mandelboim Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells Cell Host Microbe 5 2009 376 385
199. R.L. Skalsky, M.A. Samols, K.B. Plaisance, I.W. Boss, A. Riva, M.C. Lopez, H.V. Baker, and R. Renne Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 J Virol 81 2007 12836 12845